Found: 5
Select item for more details and to access through your institution.
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01398-5
- By:
- Publication type:
- Article
P2‐076: GENERATION OF AD ANIMAL MODELS USING A NOVEL RNA‐GUIDED GENE EDITING TECHNOLOGY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P601, doi. 10.1016/j.jalz.2019.06.2483
- By:
- Publication type:
- Article
Metabolic resistance of Aβ3pE-42, a target epitope of the anti-Alzheimer therapeutic antibody, donanemab.
- Published in:
- Life Science Alliance, 2024, v. 7, n. 12, p. 1, doi. 10.26508/lsa.202402650
- By:
- Publication type:
- Article
The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain.
- Published in:
- Science Signaling, 2024, v. 17, n. 848, p. 1, doi. 10.1126/scisignal.adk1822
- By:
- Publication type:
- Article
Introduction of pathogenic mutations into the mouse Psen1 gene by Base Editor and Target-AID.
- Published in:
- Nature Communications, 2018, v. 9, p. 1, doi. 10.1038/s41467-018-05262-w
- By:
- Publication type:
- Article